NewslettersHuman Immunology News S-531011, a Novel Anti-Human CCR8 Antibody, Induces Potent Anti-Tumor Responses through Depletion of Tumor-Infiltrating CCR8-Expressing Regulatory T Cells By Bob - July 11, 2023 0 Investigators developed a novel humanized anti-CCR8 monoclonal antibody, S-531011, aimed as a cancer immunotherapy strategy for patients with cancer. [Molecular Cancer Therapeutics] Abstract